SPL 4.40% 9.5¢ starpharma holdings limited

Someone please explain to sarge CEO's reasoning for pausing the...

  1. 4,884 Posts.
    lightbulb Created with Sketch. 268
    Someone please explain to sarge CEO's reasoning for pausing the DEPGEM trials, I thought it was a sound considered decision to save ongoing costs and to concentrate assets on getting current three DEP in house drugs phase 2 completed and through to licencing. I also now believe that licencing negotiations are now happening, the CEO was insistent on few occasions that these negotiations are happening now.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.004(4.40%)
Mkt cap ! $38.76M
Open High Low Value Volume
9.2¢ 9.6¢ 9.2¢ $80.46K 855.4K

Buyers (Bids)

No. Vol. Price($)
1 28057 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.6¢ 6676 5
View Market Depth
Last trade - 15.57pm 26/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.